Latest TapImmune Inc. Stories
Analysis of Phase I Trial indicates Safety and positive immune response data in 21 of 21 patients administered Folate Receptor Alpha Vaccine for breast and ovarian cancers SEATTLE,
Exercise in Full of Strategically Designed Warrant Package SEATTLE, Jan. 12, 2015 /PRNewswire/ -- TapImmune, Inc.
Vaccine & Gene Therapy Institute of Florida to provide expertise in vaccine development and clinical trial design SEATTLE, Nov. 18, 2014 /PRNewswire/ --TapImmune, Inc.
- An imitative word; an onomatopoetic word.